Verastem Oncology annonce l'acceptation par la FDA et l'examen prioritaire de la demande de nouveau médicament pour l'avutométinib en association avec le défactinib pour le traitement du cancer de l'ovaire séreux de bas grade récurrent mutant KRAS.
Verastem Oncology annonce l'acceptation par la FDA et l'exame…
Dec 30, 2024
zonebourse.com
Research | Verastem, Inc.
Research | Verastem, Inc.
11 months ago
verastem.com
Dr Monk on Avutometinib Plus Defactinib in Low-Grade Serous Ovarian Cancer | OncLive
Dr Monk on Avutometinib Plus Defactinib in Low-Grade Serous O…
1 week ago
onclive.com
Interpreting Results From RAMP 201: Avutometinib /- Defactinib in Recurrent LGSOC | OncLive
Interpreting Results From RAMP 201: Avutometinib /- Defactinib in …
Nov 3, 2023
onclive.com
Verastem Oncology publie de nouvelles données positives sur l'étude de phase 1/2 de GenFleet Therapeutics en Chine pour le GFH375 (VS-7375) dans l'adénocarcinome canalaire pancréatique mutant KRAS G12D
Verastem Oncology publie de nouvelles données positives sur l'…
4 months ago
zonebourse.com
Verastem Oncology provides update on Ramp 203 phase 1/2 clinical trial
Verastem Oncology provides update on Ramp 203 phase 1/2 clinical trial
1 month ago
marketscreener.com
Verastem Oncology and STAAR Ovarian Cancer Foundation Establish the Inaugural Low-Grade Serous Ovarian Cancer (LGSOC) Awareness Day on September 9, 2024
Verastem Oncology and STAAR Ovarian Cancer Foundation Establ…
Sep 3, 2024
financialpost.com
Verastem Oncology announces transition plan to accelerate next …
2 months ago
marketscreener.com
0:11
The World Ovarian Cancer Coalition is grateful to partners like Veraste…
41 views2 weeks ago
FacebookWorld Ovarian Cancer Coalition
Pipeline | Verastem, Inc.
2 weeks ago
verastem.com
1:34
Exclusive Interview with Dr. Jonathan Pachter, Chief Scientific …
67 views7 months ago
YouTubeGeneOnline 基因線上
Hedge Funds Never Loved Verastem Inc (VSTM) More
Jun 24, 2020
insidermonkey.com
1:36
Efficiency Meets Care: Transforming Healthcare with Veradigm
53.6K viewsNov 22, 2023
YouTubeVeradigm®
Verastem (NASDAQ:VSTM) shareholders have endured a 62% …
Aug 12, 2022
nasdaq.com
3:51
Oncology Update by LucidQuest Episode 25
12 views7 months ago
YouTubeLucidQuest
Vstm Stock Quote: Verastem's Rise in Cancer-Focused Trading
5 months ago
cgaa.org
41:31
Evolving strategies in low-grade serous ovarian cancer: Applying t…
44 views1 month ago
YouTubeTouch Medical Media
1:58
How the Veradigm Network Transforms Healthcare with Real-…
760 viewsAug 21, 2024
YouTubeVeradigm®
9:03
Low-Grade Serous Ovarian Cancer
6.1K viewsDec 2, 2019
YouTubeOncLive
6:21
Alexey Danilov, ASH 2019: Advancing the Role of BTK Inhibit…
203 viewsDec 18, 2019
YouTubeTouch Medical Media
3:20
What is Veritaseum & What Does It Do?
9.4K viewsMar 29, 2018
YouTubeReggie Middleton
24:58
Know Your Company | AstraZeneca: Leading Revolution In Oncology | …
1.5K viewsDec 2, 2024
YouTubeNDTV Profit
35:02
Inside Cancer Innovation Radiopharm ASX RAD Shares Wh…
182 views5 months ago
YouTubeKalkine Media
What Is VeriSM—and Is It the Next Generation of ITSM?
Sep 30, 2019
helixops.ai
1:38:34
KRAS Cancer Clinical Trial Updates: What Patients Need to Know from …
27.9K views8 months ago
YouTubeKRAS Cancer Kickers
0:44
Precision Oncology Breakthroughs Draw Institutional Backing As Mar…
1.5K views3 months ago
YouTubeUSA News Group
23:42
5th Annual World Ovarian Cancer Coalition Impact Awards
1 views2 months ago
YouTubeWorld Ovarian Cancer Coalition
0:22
Transforming Health, Insightfully with the Veradigm Network
1.4M viewsDec 3, 2024
YouTubeVeradigm®
2:04
FDA Approves First Gene Therapy To Successfully Treat Cancer | NB…
28K viewsJul 12, 2017
YouTubeNBC News
22:31
The ImmunoVerse: (Ep. 4) Targeting KRAS: A New Era for Pancreatic C…
281 views5 months ago
YouTubeMoffitt Cancer Center
See more videos
Static thumbnail place holder